Quick Answer
PRECISION BIOSCIENCES INC reported Diluted EPS of $3.56 per share (loss) for fiscal year 2025.
PRECISION BIOSCIENCES INC Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$3.56 | -442.3% |
| 2024 | $1.04 | +106.5% |
| 2023 | -$15.96 | +58.1% |
| 2022 | -$38.10 | -7226.9% |
| 2021 | -$0.52 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.84 | +18.2% | +13.6% |
| June 30, 2025 | -$2.13 | -145.6% | +3.6% |
| March 31, 2025 | -$2.21 | -230.0% | +1.8% |
| September 30, 2024 | -$2.25 | -7.1% | -148.2% |
| June 30, 2024 | $4.67 | +249.2% | +174.7% |
| March 31, 2024 | $1.70 | +125.2% | +181.0% |
| September 30, 2023 | -$2.10 | -854.5% | +32.9% |
| June 30, 2023 | -$3.13 | -580.4% | +53.6% |
- PRECISION BIOSCIENCES INC showed a decrease of -442.3% in Diluted EPS compared to the prior fiscal year.
- Over the 2021–2025 period, PRECISION BIOSCIENCES INC’s diluted eps has declined by 584.6% (from $0.52 per share (loss) to $3.56 per share (loss)).
- The most recent figure is from PRECISION BIOSCIENCES INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: